Erb K, Ditzel H, Waever-Rasmussen J, Borup-Christensen P, Jensenius J C
Department of Med. Microbiologi, University of Odense, Denmark.
Hum Antibodies Hybridomas. 1991 Oct;2(4):215-21.
We have compared by SDS-PAGE Western blotting the molecules detected by two human monoclonal antibodies, C-OU1 and 16.88. The antibodies have previously been shown to detect a cytoplasmatic antigen with an Mr of 43 kD present in colon adenocarcinoma cell lines and in colon cancer tissues. We now demonstrate that these antibodies differ significantly in their fine specificity, resulting in a quite dissimilar tumor selectivity. The antibody 16.88, in addition to reactivity with the 43-kD molecule, also recognizes a 190-kD molecule present both in melanoma cells and in cells previously reported as 16.88 antigen positive. The 16.88 antibody does not detect a 43-kD molecule in extracts of melanoma cells. The 190-kD component was not detectable in hepatoma or mamma carcinoma cells, both of which showed presence of the 43-kD molecule. The C-OU1 antibody shows no reactivity with the 190-kD molecule in any of the cells tested or with other proteins in melanoma cells. Radiolabeled 16.88 antibody shows better localization to melanoma cancer than to colon cancer xenograft transplanted onto nude mice. These findings indicate the presence of a tumor-associated antigen not previously described and have obvious implications for potential clinical uses of the antibodies.
我们通过SDS - PAGE免疫印迹法比较了两种人单克隆抗体C - OU1和16.88所检测到的分子。先前已证明这两种抗体可检测到结肠腺癌细胞系和结肠癌组织中存在的一种分子量为43 kD的细胞质抗原。我们现在证明,这些抗体在精细特异性上有显著差异,导致肿瘤选择性相当不同。抗体16.88除了与43 - kD分子反应外,还识别黑色素瘤细胞和先前报道为16.88抗原阳性的细胞中都存在的一种190 - kD分子。16.88抗体在黑色素瘤细胞提取物中检测不到43 - kD分子。在肝癌细胞或乳腺癌细胞中均未检测到190 - kD成分,这两种细胞均显示存在43 - kD分子。C - OU1抗体在所测试的任何细胞中均未显示与190 - kD分子反应,也未与黑色素瘤细胞中的其他蛋白质反应。放射性标记的16.88抗体在裸鼠移植的黑色素瘤上的定位比在结肠癌异种移植瘤上更好。这些发现表明存在一种先前未描述的肿瘤相关抗原,并且对这些抗体的潜在临床应用具有明显的意义。